The global biopsy devices market size is expected to reach USD 3.69 billion by 2028 at a CAGR of 7.1%, according to the latest report by Reports and Data. Rising prevalence of cancer, rise in government initiatives to raise cancer awareness worldwide, increasing need for early diagnosis and prevention of cancer, and growing adoption of minimally invasive surgeries are among the most important parameters expected to drive growth of the global biopsy devices market over the forecast period. Other significant factors driving steady growth of this market are rising prevalence of chronic and infectious diseases, growing adoption of cutting-edge imaging technologies including Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), rapidly advancing global healthcare infrastructure, and increased spending on healthcare services.  

Biopsies are medical procedures performed to examine the cause of a particular disease. This process involves removal of tissue from affected part of the body to examine it for disease. They are generally performed for detection of cancers, renal diseases, peptic ulcers, liver inflammation, and various other infections. Punch biopsy, needle biopsy, endoscopic biopsy, fine needle aspiration, and excisional and incisional biopsies are the most widely performed biopsy procedures. With technological advancements in biopsy systems and integration of advanced imaging techniques, such as MRI, CT, ultrasound, and x-ray, the global market has gained rapid traction over recent years. Moreover, increased awareness about benefits offered by biopsy over other invasive diagnostic procedures, such as smaller incisions, lesser pain and scarring, and quicker recovery, is yet another factor expected to propel the global market growth. However, risks associated with surgical biopsies including excessive bleeding, pain and infection in surgical site, and damage to surrounding organs or tissue are predicted to limit market growth to a significant extent.

Market Overview:

The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviors are shifting in a variety of ways, from the growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.

Key Players covered in this report are:

Medtronic Plc, Argon Medical Devices, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Boston Scientific Corporation, Fujifilm Holdings Corp., Cardinal Health, Inc., Danaher Corporation (Leica Microsystem), Hologic, Inc., Devicor Medical Products, Inc., Cook Medical, Inc., Olympus Corporation, INRAD, Inc., and C. R. Bard, Inc.

By Product Type (Revenue, USD Billion; 2018-2028)

• Needle-based Biopsy Instruments
  • Core Biopsy Devices
    • Core Biopsy Guns
    • Core Biopsy Needles
  • Vacuum-assisted Biopsy Devices
    • Vacuum-assisted Biopsy Systems
    • Vacuum-assisted Biopsy Needles
  • Aspiration BiopsyNeedles
• Manual and Robotic Biopsy Guidance Systems
• Biopsy Forceps
• Procedure Trays
• Localization Wires
• Others (brushes, punches, curettes, etc.)

By Imaging Technique (Revenue, USD Billion; 2018-2028)

• Ultrasound-guided Biopsy
• Stereotactic-guided Biopsy
• MRI-guided Biopsy
• CT Scan
• Others

By Application (Revenue, USD Billion; 2018-2028)

• Lung biopsy
• Liver biopsy
• Kidney biopsy
• Gastroenterological biopsy
• Gynecological biopsy
• Breast biopsy 
• Prostate biopsy
• Others 

By End-use (Revenue, USD Billion; 2018-2028)

• Hospitals
• Diagnostic and Imaging Centers
• Academic Research Institutes
• Others

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East Africa

Request a sample Report of Biopsy Devices Market @ https://www.reportsanddata.com/request-customization-form/4048 

Major Points covered in this report are as below:

• The Biopsy Devices industry development trends and marketing channels are analyzed. The feasibility of new investment projects is assessed and overall research conclusions are offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes, and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue, and gross margins.

• The Biopsy Devices Market report provides key statistics on the market status of the Biopsy Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.